Cargando…
Redundant trials can be prevented, if the EU clinical trial regulation is applied duly
The problem of wasteful clinical trials has been debated relentlessly in the medical community. To a significant extent, it is attributed to redundant trials – studies that are carried out to address questions, which can be answered satisfactorily on the basis of existing knowledge and accessible ev...
Autores principales: | Kim, Daria, Hasford, Joerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592564/ https://www.ncbi.nlm.nih.gov/pubmed/33115456 http://dx.doi.org/10.1186/s12910-020-00536-9 |
Ejemplares similares
-
Applying implementation frameworks to the clinical trial context
por: Stensland, Kristian D., et al.
Publicado: (2022) -
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
por: Schwarz, Sally W., et al.
Publicado: (2019) -
Why meta-regulation matters for public health: the case of the EU better regulation agenda
por: Lauber, Kathrin, et al.
Publicado: (2023) -
Innovative regenerative medicines in the EU: a better future in evidence?
por: Corbett, Mark S., et al.
Publicado: (2017) -
Digital health technologies and Alzheimer’s disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
por: Leroy, Victoire, et al.
Publicado: (2023)